With the swift progression in the
field of biomedical/healthcare technology, companies operating in the
healthcare/pharmaceutical/therapeutic industry are now surmounting in the
respective realm. Also, on account of the escalating incidences of health
related issues originating due to changing lifestyle and continuously changing
surroundings, blood plasma industry’s growth is augmented, especially in the
segment of immunoglobulins.
In order to address the unmet
medical needs related to blood disorders, autoimmune diseases and liver
function impairment among others, associated companies are coming up with novel
and improved treatment options like IVIG, albumin, clotting factors etc. which are
derived from human blood plasma.
Plasma is the liquid component of
blood, constituting around 50% of the total blood volume. Plasma in itself is
approximately 90% water, with the remaining 10% comprising of proteins,
minerals, clotting factors, hormones, and immunoglobulins. Plasma is the raw
material for the extraction of various proteins which are used for their
therapeutic values. IgG is naturally manufactured by plasma cells in human
body. IgG antibody, also known as immunoglobulin-G is a large Y-shaped protein
employed by the body’s immune system for neutralizing foreign substances like
viruses and bacteria.
To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/global-ivig-market-report-2013-edition
Intravenous immunoglobulin (IVIG) is
a blood plasma derivative administered intravenously. It comprises of pooled,
polyvalent, IgG (immunoglobulin (antibody) G) extracted from the plasma of more
than one thousand blood donors. The very blood plasma derivative is deployed
mainly in the treatment of autoimmune disorders, immune deficiencies and acute
infections. IVIG has been the key factor to drive the growth of plasma products
industry. The demand for IVIG has been growing on account of its increased
usage in the treatment of primary immunodeficiency as well as newer
neurological indications.
The present report offers an
analysis of the global IVIG market with a special focus on the IVIG market of
the US. The market is characterized by fast pace developments in the clinical
technology and testing methodology. Despite challenges like stringent
regulations and high cost of treatment, the global IVIG market is all set to
witness high growth in the coming years as a result of growing ageing
population, increasing number of patients with bleeding disorder, and rising
health expenditure. Furthermore, the competitive landscape of the industry is
highlighted. The rivalry prevalent in the global IVIG plasma market is quite
fierce with numerous local and global players contenting for the market share.
On the global front, the key players are Baxter, CSL, and Grifols.
By combining SPSS Inc.’s data
integration and analysis capabilities with our relevant findings, we have
predicted the future growth of the industry. We employed various significant
variables that have an impact on this industry and created regression models
with SPSS Base to determine the future direction of the industry. Before
deploying the regression model, the relationship between several independent or
predictor variables and the dependent variable was analyzed using standard SPSS
output, including charts, tables, and tests.
To Buy The Copy of
This Report Visit: http://www.marketresearchreports.biz/analysis/170274
About Us
MarketResearchReports.Biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are especially designed to save time and
money of our clients. We are a one stop solution for all your research needs,
our main offerings are syndicated research reports, custom research,
subscription access and consulting services. We serve all sizes and types of
companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948
